Old Web
English
Sign In
Acemap
>
Paper
>
Ocrelizumab: A New Generation of anti‐ CD20 mAb for Treatment of Multiple Sclerosis
Ocrelizumab: A New Generation of anti‐ CD20 mAb for Treatment of Multiple Sclerosis
2019
Andrew C. Chan
Paul Brunetta
Peter Chin
Keywords:
Multiple sclerosis
CD20
Ocrelizumab
Immunology
Medicine
Monoclonal antibody
anti cd20
Correction
Source
Cite
Save
Machine Reading By IdeaReader
133
References
0
Citations
NaN
KQI
[]